A detailed history of Wcm Investment Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Wcm Investment Management, LLC holds 154,675 shares of RARE stock, worth $8.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
154,675
Previous 152,500 1.43%
Holding current value
$8.59 Million
Previous $7.12 Million 10.72%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$37.42 - $51.61 $81,388 - $112,251
2,175 Added 1.43%
154,675 $6.36 Million
Q1 2024

Apr 25, 2024

BUY
$43.02 - $53.69 $1.36 Million - $1.69 Million
31,515 Added 26.05%
152,500 $7.12 Million
Q4 2023

Jan 29, 2024

BUY
$31.73 - $49.19 $419,470 - $650,291
13,220 Added 12.27%
120,985 $5.79 Million
Q3 2023

Oct 10, 2023

BUY
$34.92 - $46.66 $85,903 - $114,783
2,460 Added 2.34%
107,765 $3.84 Million
Q2 2023

Jul 14, 2023

BUY
$37.35 - $52.15 $279,676 - $390,499
7,488 Added 7.66%
105,305 $4.86 Million
Q1 2023

May 15, 2023

BUY
$36.99 - $48.71 $38,728 - $50,999
1,047 Added 1.08%
97,817 $3.92 Million
Q4 2022

Feb 06, 2023

BUY
$33.72 - $46.33 $226,429 - $311,105
6,715 Added 7.46%
96,770 $4.48 Million
Q3 2022

Oct 18, 2022

BUY
$39.96 - $66.14 $264,215 - $437,317
6,612 Added 7.92%
90,055 $3.65 Million
Q2 2022

Aug 09, 2022

SELL
$45.8 - $85.4 $7,511 - $14,005
-164 Reduced 0.2%
83,443 $5.03 Million
Q1 2022

May 06, 2022

BUY
$62.2 - $84.4 $429,055 - $582,191
6,898 Added 8.99%
83,607 $6.07 Million
Q4 2021

Jan 26, 2022

BUY
$73.71 - $87.86 $243,021 - $289,674
3,297 Added 4.49%
76,709 $6.45 Million
Q3 2021

Nov 02, 2021

BUY
$77.92 - $102.4 $39,427 - $51,814
506 Added 0.69%
73,412 $6.62 Million
Q2 2021

Aug 05, 2021

BUY
$92.19 - $115.71 $261,911 - $328,732
2,841 Added 4.05%
72,906 $6.95 Million
Q1 2021

May 13, 2021

SELL
$106.9 - $167.73 $177,881 - $279,102
-1,664 Reduced 2.32%
70,065 $7.98 Million
Q4 2020

Feb 16, 2021

BUY
$84.4 - $177.39 $330,594 - $694,836
3,917 Added 5.78%
71,729 $9.93 Million
Q3 2020

Nov 06, 2020

BUY
$72.98 - $90.0 $304,034 - $374,940
4,166 Added 6.55%
67,812 $5.57 Million
Q2 2020

Aug 18, 2020

BUY
$46.91 - $78.22 $97,338 - $162,306
2,075 Added 3.37%
63,646 $4.98 Million
Q1 2020

May 08, 2020

BUY
$33.8 - $62.9 $2.08 Million - $3.87 Million
61,571 New
61,571 $2.74 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.89B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.